Tapewire

Nasdaq · USD

PHVS

Pharvaris N.V.

Export transactions ↓
Tapewire entity
4374
SEC CIK
0001830487
Parsed reports
70

Last 12 months

Inside the activity.

0 purchase rows · 71 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 2026022
May 2026012
Jun 2026017
Jul 202601
Aug 202601
Sep 2026018
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 22, 2026 Filed Apr 24, 2026 18:09 UTC SaleCommon Stock 7,000 $30.05 $210,378.70
Disclosure

SEC source: 0001193125-26-176673 · ownership.xml · nonDerivative · entry 1

Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 388,167

F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan.

F2 · price: These shares were sold in multiple transactions at prices ranging from $30 - $30.13.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 16:18 UTC
Lesage AnneChief Early Development
Exercise / conversionStock Option (Right to Buy) · Derivative 7,000 $0.00 Strike: $8.05 $0.00
Disclosure

SEC source: 0001193125-26-176222 · ownership.xml · derivative · entry 10

Lesage Anne · CIK 0001973705 · Chief Early Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,000

Underlying: Common Stock · 7,000 shares

Expires 2031-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan.

F5 · derivative.exercise_date: 25% of the option vested on February 5, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 16:18 UTC
Lesage AnneChief Early Development
Exercise / conversionStock Option (Right to Buy) · Derivative 500 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001193125-26-176222 · ownership.xml · derivative · entry 9

Lesage Anne · CIK 0001973705 · Chief Early Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,972

Underlying: Common Stock · 500 shares

Expires 2030-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan.

F4 · derivative.exercise_date: 25% of the option vested on January 1, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 16:18 UTC
Lesage AnneChief Early Development
SaleCommon Stock 7,000 $30.05 $210,357.70
Disclosure

SEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 5

Lesage Anne · CIK 0001973705 · Chief Early Development

10b5-1 filing: Plan reported

Ownership: Indirect · GrayMatters Consulting B.V.

Disclosed balance after: 156,969

F2 · price: These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 16:18 UTC
Lesage AnneChief Early Development
SaleCommon Stock 7,000 $30.05 $210,361.90
Disclosure

SEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 4

Lesage Anne · CIK 0001973705 · Chief Early Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,450

F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan.

F2 · price: These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 16:18 UTC
Lesage AnneChief Early Development
Exercise / conversionCommon Stock 7,000 $8.05 $56,350.00
Disclosure

SEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 3

Lesage Anne · CIK 0001973705 · Chief Early Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,450

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 16:18 UTC
Lesage AnneChief Early Development
SaleCommon Stock 500 $30.00 $15,000.00
Disclosure

SEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 2

Lesage Anne · CIK 0001973705 · Chief Early Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,450

F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 16:18 UTC
Lesage AnneChief Early Development
Exercise / conversionCommon Stock 500 $2.59 $1,295.00
Disclosure

SEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 1

Lesage Anne · CIK 0001973705 · Chief Early Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 15:27 UTC
Lu PengChief Medical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 7,001 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001193125-26-175965 · ownership.xml · derivative · entry 5

Lu Peng · CIK 0001972159 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,307

Underlying: Common Stock · 7,001 shares

Expires 2030-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan.

F4 · derivative.exercise_date: 25% of the option vested on February 3, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 15:27 UTC
Lu PengChief Medical Officer
SaleCommon Stock 7,001 $30.05 $210,401.75
Disclosure

SEC source: 0001193125-26-175965 · ownership.xml · nonDerivative · entry 2

Lu Peng · CIK 0001972159 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,083

F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan.

F2 · price: These shares were sold in multiple transactions at prices ranging from $30 - $30.15.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 15:27 UTC
Lu PengChief Medical Officer
Exercise / conversionCommon Stock 7,001 $2.59 $18,132.59
Disclosure

SEC source: 0001193125-26-175965 · ownership.xml · nonDerivative · entry 1

Lu Peng · CIK 0001972159 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,084

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:38 UTC
Lu PengChief Medical Officer
Tax withholdingCommon Stock 226 $28.78 $6,504.28
Disclosure

SEC source: 0001193125-26-164355 · ownership.xml · nonDerivative · entry 1

Lu Peng · CIK 0001972159 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,083

F1 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units on April 11, 2026 and April 12, 2026. The shares were withheld on April 16, 2026 at a fair market value of $28.78 per share.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 19:00 UTC
Modig BerndtDirector · Chief Executive Officer
SaleCommon Stock 2,292 $28.60 $65,558.53
Disclosure

SEC source: 0001193125-26-163713 · ownership.xml · nonDerivative · entry 1

Modig Berndt · CIK 0001643072 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 139,792

F1 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $28.32 to $28.82. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
April 11, 2026 Filed Apr 14, 2026 21:52 UTC
Nijdam AnnaPrincipal Accounting Officer
Tax withholdingCommon Stock 548 $26.63 $14,593.24
Disclosure

SEC source: 0001193125-26-155193 · ownership.xml · nonDerivative · entry 1

Nijdam Anna · CIK 0001973872 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,940

F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 17:42 UTC
Modig BerndtDirector · Chief Executive Officer
SaleCommon Stock 200 $28.42 $5,683.00
Disclosure

SEC source: 0001193125-26-150954 · ownership.xml · nonDerivative · entry 2

Modig Berndt · CIK 0001643072 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,084

F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $28.32 to $28.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 17:42 UTC
Modig BerndtDirector · Chief Executive Officer
SaleCommon Stock 23,133 $27.74 $641,598.38
Disclosure

SEC source: 0001193125-26-150954 · ownership.xml · nonDerivative · entry 1

Modig Berndt · CIK 0001643072 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,284

F1 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $27.31 to $28.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
April 06, 2026 Filed Apr 8, 2026 19:00 UTC
Nijdam AnnaPrincipal Accounting Officer
Tax withholdingCommon Stock 1,167 $28.56 $33,329.52
Disclosure

SEC source: 0001973872-26-000014 · ownership.xml · nonDerivative · entry 1

Nijdam Anna · CIK 0001973872 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,488

F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 18:07 UTC
Nijdam AnnaPrincipal Accounting Officer
Tax withholdingCommon Stock 1,164 $28.25 $32,883.00
Disclosure

SEC source: 0001973872-26-000010 · ownership.xml · nonDerivative · entry 1

Nijdam Anna · CIK 0001973872 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,655

F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.